John Wiley and Sons Ltd provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Journal of Labelled Compounds and Radiopharmaceuticals (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Journal of Labelled Compounds and Radiopharmaceuticals published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Chemistry, Analyticalrank 102 of 123 journals
- Chemistry, Medicinalrank 71 of 74 journals
- Biochemical Research Methodsrank 85 of 86 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Journal of Labelled Compounds and Radiopharmaceuticals
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Labelled Compounds and Radiopharmaceuticals is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$3,800.
02Review time
Review time of Journal of Labelled Compounds and Radiopharmaceuticals
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Journal of Labelled Compounds and Radiopharmaceuticals published between Nov 2024 and Oct 2026 were accepted within 78 days of submission, and the middle half took between 57 and 147 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Chemistry, Analytical, Journal of Labelled Compounds and Radiopharmaceuticals ranks 12 of 42 journals by review time (1 = fastest). See the fastest-review journals in Chemistry, Analytical →
03Fee waivers
APC waivers and discounts for Journal of Labelled Compounds and Radiopharmaceuticals
Journal of Labelled Compounds and Radiopharmaceuticals follows the waiver policy of its publisher, Wiley: full waiver or 50% discount by Wiley's country list (close to Research4Life), applied automatically when enough of the authors are eligible. The corresponding author's country decides the group, and for a full waiver at least half of all authors must be affiliated in a country of the same eligible group.
Authors affiliated in 84 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Journal of Labelled Compounds and Radiopharmaceuticals is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at Journal of Labelled Compounds and Radiopharmaceuticals
Most common reasons (a retraction can have several):
Journal of Labelled Compounds and Radiopharmaceuticals has 1 retracted paper in the Retraction Watch database, the latest in Dec 2010. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
Who funds research published in Journal of Labelled Compounds and Radiopharmaceuticals
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Journal of Labelled Compounds and Radiopharmaceuticals? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
04Indexing
Indexing of Journal of Labelled Compounds and Radiopharmaceuticals
- ISSN
- 0362-4803
- eISSN
- 1099-1344
- Publisher
- John Wiley and Sons Ltd all its journals →
- Country
- England
- Language
- Multi-Language
- Scopus source type
- Journal
- Web of Science categories
- Biochemical Research Methods, Chemistry, Medicinal, Chemistry, Analytical
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Journal of Labelled Compounds and Radiopharmaceuticals
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Journal of Labelled Compounds and Radiopharmaceuticals accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. John Wiley and Sons Ltd offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Journal of Labelled Compounds and Radiopharmaceuticals is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Journal of Labelled Compounds and Radiopharmaceuticals
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Journal of Labelled Compounds and Radiopharmaceuticals, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
07Same subject
Chemistry, Analytical journals with a similar impact factor*
The journals next to Journal of Labelled Compounds and Radiopharmaceuticals when the 109 journals of Chemistry, Analytical in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 98 | Journal of Water Chemistry and Technology | 1.02 | SCIE | Subscription |
| 99 | Studies in Conservation | 0.96 | AHCI, SCIE | Subscription |
| 100 | Chinese Journal of Chromatography | 0.90 | ESCI | Subscription |
| 101 | Journal of Chemical Metrology | 0.81 | ESCI | Some open access |
| 103 | METHODS AND OBJECTS OF CHEMICAL ANALYSIS | 0.60 | ESCI | Some open access |
| 104 | French-Ukrainian Journal of Chemistry | 0.42 | ESCI | Fully open access |
| 105 | Pakistan Journal of Analytical & Environmental Chemistry | 0.42 | ESCI | Fully open access |
| 106 | Brazilian Journal of Analytical Chemistry | 0.39 | ESCI | Some open access |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
08Journal Finder
Find the right journal for your paper
Is Journal of Labelled Compounds and Radiopharmaceuticals right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,724 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Journal of Labelled Compounds and Radiopharmaceuticals?
Based on 67 research articles Journal of Labelled Compounds and Radiopharmaceuticals published from Nov 2024 to Oct 2026, the median time from submission to acceptance was 78 days, and half of them were accepted between 57 and 147 days. After acceptance, papers appeared online after a median of 16 days. Source: received and accepted dates deposited by the publisher in Crossref, retrieved October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Journal of Labelled Compounds and Radiopharmaceuticals?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Journal of Labelled Compounds and Radiopharmaceuticals is 0.61: papers it published in the two previous years were cited 0.61 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Journal of Labelled Compounds and Radiopharmaceuticals?
The h-index of Journal of Labelled Compounds and Radiopharmaceuticals is 66 (OpenAlex, October 2026): 66 of its papers have each been cited at least 66 times. Its i10-index is 1,494.
What is the APC of Journal of Labelled Compounds and Radiopharmaceuticals?
OpenAlex lists an article processing charge (APC) of about US$3,800 for Journal of Labelled Compounds and Radiopharmaceuticals (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Journal of Labelled Compounds and Radiopharmaceuticals?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Labelled Compounds and Radiopharmaceuticals is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Journal of Labelled Compounds and Radiopharmaceuticals indexed in Scopus?
Yes. Journal of Labelled Compounds and Radiopharmaceuticals appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Labelled Compounds and Radiopharmaceuticals an SCIE journal?
Yes. Journal of Labelled Compounds and Radiopharmaceuticals is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Labelled Compounds and Radiopharmaceuticals in Journal Citation Reports (JCR)?
Yes. Journal of Labelled Compounds and Radiopharmaceuticals is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Journal of Labelled Compounds and Radiopharmaceuticals offer an APC waiver?
Journal of Labelled Compounds and Radiopharmaceuticals follows the policy of Wiley: full waiver or 50% discount by Wiley's country list (close to Research4Life), applied automatically when enough of the authors are eligible. The corresponding author's country decides the group, and for a full waiver at least half of all authors must be affiliated in a country of the same eligible group. Rules verified 27 October 2026; confirm on the publisher's page.
Has Journal of Labelled Compounds and Radiopharmaceuticals retracted papers?
Yes. The Retraction Watch database lists 1 retracted paper in Journal of Labelled Compounds and Radiopharmaceuticals, 0 of them in the last 10 years; the most common reasons are duplication of/in article. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Journal of Labelled Compounds and Radiopharmaceuticals?
34% of 92 recent research articles in Journal of Labelled Compounds and Radiopharmaceuticals name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, National Institutes of Health, Japan Agency for Medical Research and Development.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Chemical Physics
- Energy
- Physical Review
- Journal of the Acoustical Society of America
- Frontiers in Microbiology
- Physical Review B
- Industrial and Engineering Chemistry Research
- Journal of Physical Chemistry C
- Nature Communications
- European Journal of Pharmacology
- Physics Today
- Physical Chemistry Chemical Physics
- Materials Letters
- Chemical Physics Letters
Browse all journals: indexing, impact factor and reviewer comments →